BioNTech : Fourth Quarter and Full Year 2022 Earnings Presen

Financial Results & Corporate Update


4th Quarter and Full Year 2022


27.03.2023


This Slide Presentation Includes... | March 27, 2023

Related Keywords

United States , Ryan Richardson , Ugur Sahin , Jens Holstein , Centers For Disease , Committee For Medicinal Products Human Use , European Union , European Commission , European Medicines Agency , Pfizer , Financial Results , Full Year , Private Securities Litigation Reform Act , Medicinal Products , Human Use , Product Characteristics , Package Leaflet , Emergency Use Authorization , Coronavirus Disease , Acute Allergic Reactions , Disease Control , Adverse Reactions , Adverse Reactions Identified , Post Authorization , Chief Executive , Chief Medical , Chief Financial , Chief Strategy , Biontech Se Stock Exchange , News , Information , Press Release , Financial , Results , Corporate , Ith , Quarter , End , Bull , Ear , This , Slide , Resentation Bntx Us09075v1026 ,